Race to slash TB treatment time in half
NCT ID NCT06114628
Summary
This large international trial aims to find faster, safer treatments for tuberculosis (TB). It will test 11 new drug combinations, including two promising new drugs, on up to 2,500 adults with lung TB. The goal is to shorten the standard 6-month treatment to as little as 2 months while ensuring it works just as well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Joint Clinical Research Centre
RECRUITINGKampala, Uganda
Contact
-
Kibong'oto Infectious Diseases Hospital
RECRUITINGMoshi, Tanzania
Contact
-
Makerere University Lung Institute
RECRUITINGKampala, Uganda
Contact
-
NIMR Mbeya
RECRUITINGMbeya, Tanzania
Contact
-
NIMR Mwanza
RECRUITINGMwanza, Tanzania
Contact
-
National Lung Hospital
ACTIVE_NOT_RECRUITINGHanoi, Vietnam
-
PMSI Institute of Pneumology "Chiril Draganiuc"
ACTIVE_NOT_RECRUITINGChisinau, Moldova
-
Pnth/Oucru
ACTIVE_NOT_RECRUITINGHo Chi Minh City, Vietnam
-
TASK Brooklyn
RECRUITINGCape Town, South Africa
Contact
-
TASK Eden
RECRUITINGGeorge, South Africa
Contact
-
University of Cape Town Lung Institute
RECRUITINGCape Town, South Africa
Contact
Conditions
Explore the condition pages connected to this study.